Logo
Mayne Pharma InvestorHub

Mayne Pharma Management Changes

Mayne Pharma Group Limited (Mayne Pharma or the Company) (ASX: MYX), today announces a planned leadership transition. On 20 February 2026 (US time) Mr Shawn Patrick O’Brien stepped down as Chief Executive Officer and Managing Director, and Mr Aaron Gray, currently Mayne Pharma’s Chief Financial Officer, was appointed Chief Executive Officer.
Learn More.

Share your feedback

Discover